Bullish
Thermo Fisher Scientific, a prominent Massachusetts-based biotech company, has inaugurated a new, highly anticipated lab and processing facility. The ...
Bullish
Thermo Fisher Scientific has opened its first U.S. bioprocess design center in Plainville, Massachusetts, expanding its existing 290,000-square-foot c...
Bullish
Thermo Fisher Scientific has agreed to sell its microbiology business to Astorg, a pan-European private equity firm, for approximately $1.075 billion....
Thermo Fisher Scientific (TMO) shares declined after Q1 2026 earnings, despite revenue reaching US$11.01b and GAAP diluted EPS of US$4.43, as the comp...
Neutral
Thermo Fisher Scientific announced it has signed a definitive agreement to sell its microbiology business to Astorg for approximately $1.075 billion. ...
Bullish
Thermo Fisher Scientific (NYSE: TMO) announced strong financial results for fiscal Q1 2026, with revenue rising 6% to $11.01 billion and GAAP diluted ...
Bullish
Thermo Fisher Scientific (NYSE:TMO) reported strong fiscal Q1 2026 results, with revenue rising 6% to $11.01 billion and GAAP diluted EPS growing 11% ...
Thermo Fisher Scientific (TMO) has experienced recent share price weakness, with a 7-day decline of 10.8% and a year-to-date decline of 20.7%, despite...
Neutral
Calamos Advisors LLC increased its stake in Thermo Fisher Scientific Inc. by 15% in the fourth quarter of the prior year, bringing its total holdings ...
Thermo Fisher Scientific reported a strong first quarter, with revenues up 6% to $11.01 billion and adjusted earnings per share increasing by 6% to $5...
Thermo Fisher Scientific has acquired clinical trial technology provider Clario, leading to a raised full-year revenue and EPS guidance. This acquisit...
Neutral
Thermo Fisher Scientific (TMO) reported Q4 2025 revenue of US$12.2 billion and basic EPS of US$5.22, with trailing twelve-month revenue at US$44.6 bil...
Bullish
Thermo Fisher Scientific developed the FluidEase Pro ClipTip, its first handheld pipette with a large touchscreen, over 2.5 years and 20 software revi...
Thermo Fisher Scientific (TMO) has introduced a new PCR instrument and formed data-driven partnerships, leading to mixed stock performance. While the ...
This article analyzes Thermo Fisher Scientific (TMO) using two valuation approaches: Discounted Cash Flow (DCF) and Price-to-Earnings (P/E) ratio. The...
Bullish
Thermo Fisher Scientific (TMO) is set to release its Q1 2026 earnings before market open on Thursday, April 23rd, with analysts expecting $5.25 EPS an...
Neutral
Thermo Fisher Scientific (TMO) has recently announced several collaborations, including a data partnership with HealthVerity and a proteomics alliance...
Bullish
Thermo Fisher Scientific Inc (TMO) shares rose 3.6% today, with a current price of $514.23, indicating an 11.1% undervaluation compared to its GF Valu...
This article analyzes Thermo Fisher Scientific's (TMO) stock valuation after recent share price movements. Using a Discounted Cash Flow (DCF) model, t...
Neutral
Wallace Advisory Group LLC decreased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 74.0% during the fourth quarter of 2025, selling 1,717 s...